Creditors Reject Braskem Debt Deal, Bankruptcy Filing Risk Rises Before Nov 22 Deadline
BAK sits 31% above its 52-week low of $0.743.
Summary
Creditors rejected Braskem's latest restructuring proposal, and the stock fell 14% Monday with a November 22 deadline looming and bankruptcy protection now a real possibility. The rejected package paired a $1.1B shareholder capital injection with $2.9B of debt-to-equity conversion, and could have scaled to $1.4B and $3.8B if performance metrics were met. Some creditors are drafting a counterproposal and talks continue, so the door is not closed. This follows the October 26 6-K laying out competing term sheets from the company and the creditor group, and the November 13 6-K whose 3Q26 statements already carried a going-concern warning. The company's cash has been drained by a salt-mine environmental disaster and a long petrochemical downturn, and it now sits at a fraction of its former investment-grade standing. The November 22 deadline is the line in the sand: a deal or a filing.
At the time of this announcement, BAK was trading at $0.97 on NYSE in the Manufacturing sector, with a market capitalization of approximately $462.1M. The 52-week trading range was $0.74 to $5.40. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Seeking Alpha.